A Critical Review of Shilajatvadi Lauha WSR To Yakshma

The formulation predominantly exhibits Ushna Veerya with Katu Rasa dominance. Most ingredients possess Rasayana, Lekhana, and Srotoshodhana properties, supporting its specific indication in Yakshma. It is currently available in tablet form across various commercial price ranges.

DISCUSSION

Shilajatvadi Lauha is classically indicated in Yakshma, and its therapeutic basis can be understood through its multidimensional actions. The Rasayana property counters Dhatukshaya and supports tissue regeneration, while Lekhana and Srotoshodhana actions help clear Kapha-induced obstruction in the Pranavaha Srotas, thereby improving respiratory function. The Yogavahi nature of Shilajatu, Pippali, and Madhu enhances drug absorption and targeted delivery, augmenting overall efficacy. Lauha is described as Nanamayaghna, indicating its broad therapeutic utility. Processed Lauha Bhasma contains both Fe(II) and Fe(III) forms in nano-structured particles, which may improve absorption, iron storage, and oxygen transport—explaining its role in anaemia, weakness, and dyspnoea⁹. Tapya contributes additional Lekhana and Rasayana properties. Evidence also suggests that bhasma-based formulations can reduce airway inflammation¹⁰. Trikatu acts in Kasa and Swasa, promotes Lekhana and Srotoshodhana, and functions as a Yogavahi due to Pippali. Piperine enhances bioavailability by increasing intestinal blood flow and inhibiting P-glycoprotein and cytochrome P450 enzymes¹¹, thereby improving systemic availability of active constituents such as dibenzo-alpha-pyrones from Shilajatu and iron from Lauha Bhasma. Shilajatu has demonstrated immunomodulatory activity and enhancement of innate immune responses¹². Loha Bhasma has shown hematinic efficacy comparable to ferrous sulphate in experimental anaemia models¹³, potentially reducing anaemia-associated fatigue seen in Yakshma. Piperine’s bioenhancing effect¹⁴ further strengthens the pharmacological rationale of this formulation.

CONCLUSION

Shilajatvadi Lauha is a classical herbo-mineral formulation indicated in Yakshma, and its synergistic Rasayana, Lekhana, Yogavahi, and Srotoshodhana properties provide a rational basis for its use in conditions associated with Dhatukshaya and respiratory pathology. Compared to conventional iron salts, which frequently cause abdominal pain, nausea, and severe constipation leading to poor compliance, Shilajatvadi Lauha is generally better tolerated. Traditionally considered suitable even for children and pregnant women under supervision, it may represent a safer and more acceptable option for long-term use. Collectively, these findings provide pharmacological support for its classical indications and rationalize its use in the chronic wasting disorders (Dhatukshaya, Rajayakshma).

REFERENCE

1. Nakum JB, Vyas KY, Umretia BL, Kalsariya BD. Application of nanotechnology in Rasaushadhi preparations for nanoparticle synthesis—A comparative review. J AYUSH: Ayurveda Yoga Unani Siddha Homeopathy. 2024;13(2):1-8.
2. Tripathi I. Rasendrasarasangraha (Savimar?a ‘Rasavidyotini’ Hindi commentary). 2nd ed. Varanasi: Chaukhambha Orientalia; 1998. Yakshma Chikitsa; p. 278.
3. Govinda Das. Bhaishajya Ratnavali. Vol. 1. 1st ed. Varanasi: Chaukhambha Sanskrit Bhawan; 2006. Translated by Lochan K. p. 788.
4. Sadananda Sharma. Rasendra Sara Sangraha. Varanasi: Chaukhambha Orientalia; 2004. Lauha Kalpa Vriddhi Lakshana, Sloka 112–115. p. 128. Available from: https://archive.org/details/RasendraSaraSangraha
5. Shah NC, Bharat Bhaishajya Ratnakar. 2nd ed. New Delhi: B. Jain Publishers (Pvt) Ltd; 1999. p. 127.
6. Ministry of Health and Family Welfare, Government of India. The Ayurvedic Formulary of India. Part II. 1st English ed. New Delhi: The Controller of Publications; 2000. p. 311. The Ayurvedic Formulary of India. Pt. 2: India. Ayurvedic Pharmacopoeia Committee. https://share.google/BVTC2HbFv2dQwQ9g2
7. Sharma PV, editor. Dravyaguna Vijnana, Vol II. Varanasi: Chaukhambha Bharati Academy; 2010. Trikatu Group – Rasa, Guna, Veerya, Vipaka, Karma & Doshaghnata. p. 840–842. Available from: https://archive.org/details/dravyaguna-vijnana-pv-sharma
8. Chunekar KC, editor. Bhavaprakasha Nighantu of Bhavamishra. Varanasi: Chaukhambha Bharati Academy; 2017. Trikatu Varga, Sloka 5–9. p. 450–453. Available from: https://www.ayurvedicmedicinalplants.org/wp-content/uploads/2021/04/Bhavaprakasha-Nighantu.pdf
9. Tiwari MK, Singh A, Khooha A, Goutam UK. Structural investigation of Ayurveda Lauha (Iron) Bhasma. J Ayurveda Integr Med. 2023;14(2):100690. PMID: 36822148. Available from: https://pmc.ncbi.nlm.nih.gov/articles/PMC9978626/
10. Balkrishna A, et al. Effect of bhasma-based medicine on airway inflammation. PLoS One. 2021;16(5): e0251637. Available from: https://pubmed.ncbi.nlm.nih.gov/33965093/
11. Tripathi D, Gupta VK, Pandey P, Rajinikanth PS. Metabolic insights into drug absorption: unveiling piperine’s transformative bioenhancing potential. Pharm Res. 2025;42(10):1857–1891. doi:10.1007/s11095-025-03920-5. PMID: 41053306. Available from: https://pubmed.ncbi.nlm.nih.gov/41053306/
12. Patel S, et al. Clinical Evaluation of Shilajatu Rasayana in patients with HIV infection. [PubMed citation]. PMID: 22131681.
13. - Pandit S, Biswas TK, Debnath PK, Saha AV, Chowdhury U, Shaw BP, et al. Chemical and pharmacological evaluation of different Ayurvedic preparations of iron. J Ethnopharmacol 1999; 65: 149–56. 
14. Atal CK, Dubey RK, Singh J. Biochemical basis of enhanced drug bioavailability by piperine: evidence that piperine is a potent inhibitor of drug metabolism. J Pharmacol Exp Ther. 1985;232(1):258–262. PMID: 3917507. Available from: https://pubmed.ncbi.nlm.nih.gov/3917507/.